CD9-binding peptide

• Description :

  CD9-binding peptide is a CD9-binding peptide. CD9-binding peptide inhibits the binding of EWI-2 to CD9. CD9-binding peptide exhibits selective anti-migratory and anti-invasive activities against cancer cells. CD9-binding peptide can be used for the study of cancer[1].

• UNSPSC :

  12352209

• Target :

  Others

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Smiles :

  OC([C@H](CC1=CN=CN1)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O

• Molecular Formula :

  C45H79N21O10

• Molecular Weight :

  1074.24

• References & Citations :

  [1]Suwatthanarak T, et al. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun (Camb) . 2021 May 18;57 (40) :4906-4909.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [2843551-32-4]